Histopathologically, 78 of the 80 EGFR-mutated cases were adenocarcinoma, and the rest were adenosqumaous carcinoma (n = 1) and squamous cell carcinoma (n = 1). This evidence concerns the gene EGFR and adenocarcinoma.